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We summarize the first reported case of acquired lym-
phocytic choriomeningitis virus (LCMV) infection in
Michigan to be investigated by public health authorities and
provide evidence of the focal nature of LCMV infection in
domestic rodents. Results of serologic and virologic testing
in rodents contrasted, and negative serologic test results
should be confirmed by tissue testing.
L
ymphocytic choriomeningitis virus (LCMV) is a fre-
quently unrecognized cause of aseptic meningitis and
congenital infections in humans (1,2). First described in
1933, it is a rodentborne zoonosis associated with the com-
mon house mouse (Mus musculus) (3). Wild mice, often
infected in utero, may not develop an effective immune
response and remain asymptomatic carriers and shedders.
Large-scale outbreaks of LCMV infection in humans have
primarily been associated with contact with infected ham-
sters. Since 1960, 3 epidemics of LCMV infection involv-
ing at least 236 human cases have occurred in the United
States; all were associated with Syrian hamsters as labora-
tory animals or pets (4). LCMV is shed in the urine, feces,
saliva, milk, semen, and nasal secretions of chronically
infected rodents. Routes of human exposure include
aerosols, droplets, fomites, and direct contact with rodent
excreta or blood (3). Recently, organ transplantation has
been recognized as an additional mode of transmission for
this virus (5). We describe the first reported case of menin-
gitis due to LCMV infection in a Michigan resident.
The Case
A 46-year-old woman previously in good health came
to a community hospital emergency department on June
12, 2004, with a 1-week history of severe headache, body
aches, photophobia, weakness, and fatigue. A viral syn-
drome was diagnosed on 2 previous physician visits. Prior
medical history included migraine headaches. A complete
blood count, blood culture, serum chemistry tests, chest
radiograph, urinalysis, and lumbar puncture were per-
formed. Abnormal results included the following: cere-
brospinal fluid contained 520 leukocytes/mm3 with 100%
lymphocytes, 19 erythrocytes/mm3, protein 128.6 mg/dL,
and glucose 59 mg/dL. Serum glucose was 124 mg/dL;
serum lipase level was elevated at 686 U/L. A computed
tomographic (CT) scan of the brain without infusion
showed no evidence of acute brain process;
abdominal/pelvic scan showed inflammatory change adja-
cent to the tail of the pancreas, consistent with possible
pancreatitis.
The patient was admitted to the hospital and placed in
respiratory isolation with a diagnosis of acute meningitis,
likely of viral origin, and mild pancreatitis. She was given
supportive care with intravenous fluids, acyclovir, and
pain medication.
After consultation with an infectious disease specialist,
several diagnostic tests were performed, including serolog-
ic tests for adenovirus, Chlamydophila psittaci, antinuclear
antibodies, cytomegalovirus, LCMV, coxsackie B virus
types 1–6, and echovirus types 4, 7, 9, and 11; polymerase
chain reaction (PCR) for herpes simplex virus 1 and 2;
infectious mononucleosis screen; cryptococcal antigen
testing; and urinary mumps antibody testing. Positive
results included mumps antibody titer of immunoglobulin
G (IgG) 2.66 (negative <0.91) and IgM 1.64 (negative
<0.81), and LCMV immunofluorescence assay (IFA) titer
of IgG 256 (negative <15) and IgM 320 (negative <20).
Confirmatory testing at the Centers for Disease Control
and Prevention (CDC) in Atlanta found the specimen IgG-
reactive and negative for mumps by urinary antigen culture
and PCR. The patient was born before widespread mumps
vaccination; thus, results suggested a previous exposure.
LCMV serologic testing by enzyme-linked immunosor-
bent assay (ELISA) showed an IgG titer of 1,600 (cutoff
<100) and an IgM titer of 6,400, which indicated recent
infection.
The patient improved and was released after 7 days of
hospitalization. The family had owned 2 healthy pet rats
for 2 years, although the patient had little direct contact
with them. However, the patient reported that the family
had been battling a severe rodent infestation for 6 months,
since they no longer kept cats as pets. The family had been
trapping 4–5 mice per night in the weeks before the
patient’s illness onset. No other family members reported
illness.
Because of the substantial rodent infestation and con-
tinuing risk to others in the household, the Michigan
Department of Community Health, together with the local
health department and the US Department of Agriculture
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USAWildlife Services, received permission from the patient to
conduct a field study to determine the extent of infestation
and prevalence of infection in mice and to provide coun-
seling on health implications and control of the in-
festation.
The Investigation
Following an initial site investigation, live traps were
placed within the home and in the immediate area outdoors
(within 10 m of the residence). Traps were visited daily for
2 days. All trapping and sampling procedures were per-
formed according to CDC guidelines for sampling small
mammals for virologic testing (6,7).
On July 28 and 29, 20 animals were captured, including
17 house mice, 1 white-footed mouse (Peromyscus leuco-
pus), 1 short-tailed shrew (Blarina brevicauda), and 1 east-
ern chipmunk (Tamias striatus). Fecal pellets were also
collected from the environment, traps, and pet rats’ cage.
From July 25 to 27, the homeowner caught 6 house mice
in snap traps; the mice were frozen, and specimens were
obtained.
During necropsy, blood samples were collected by sat-
uration of Nobuto filter strips, and spleens were collected
and frozen at −70°C. Spleen tissues and fecal pellets were
homogenized, filtered, and inoculated into Vero cell cul-
tures, which were maintained every 7 days with fresh
maintenance media and observed daily for cytopathic
effect. Serologic testing was performed on the Nobuto
strips by CDC according to previously described methods
(8). All cultures were screened by IFA staining with anti-
LCMV mouse hyperimmune ascites fluid, obtained from
CDC (lot #92-0038L) and diluted 1:800 in phosphate-
buffered saline with 5% skim milk and 0.5% Tween 20 for
30 min at 37°C.
Twenty-two (96%) of 23 house mouse spleen tissue
samples showed evidence of LCMV infection by virus iso-
lation and IFA with specific LCMV antibodies. None of 14
fecal pellet suspensions showed evidence of LCMV by
virus isolation or IFA. All Nobuto strips were negative for
LCMV-specific antibodies by ELISA(Table). Confirmation
PCR of a single virus isolate was conducted at the Special
Pathogens Laboratories (CDC), and results were positive.
Five Vero cultures, positive by IFA, were observed by
negative-stain electron microscopy grid preparation. This
procedure confirmed virions consistent with an arenavirus
in all specimens tested (Figure).
Conclusions
We describe the first documented case of acquired
LCMV infection in Michigan. Evidence shows the highly
focal nature of LCMV and the potential for human illness
from exposure to the virus. Based on the patient’s course
of illness, dense rodent infestation in the patient’s home,
known routes of virus shedding, and mating and territorial
ecology of the house mouse, we infer that the high infec-
tion rates in house mice caused her infection and subse-
quent illness. Investigators could not obtain samples from
other residents of the house, so the household seropreva-
lence is undetermined.
Previous rodent serosurveys have shown focality, but
few have provided evidence of such high infection rates in
rodents. In this study, 96% of M. musculus examined were
viremic. This result may be attributable to methods used to
quantify infection status in the samples and the trapping
intensity at a single focus. Infection rates of captured
rodents may differ between rural and urban ecosystems,
parks and housing complexes, and between housing com-
plexes (8). Infection rates in natural populations have been
estimated at 2.5% (California) and 21% (Washington, DC)
(9,10). In urban Baltimore, however, single-dwelling units
in the same neighborhood showed antibody prevalence to
LCMV from 0% to 50% (8). In an LCMV epizootic of lab-
oratory mice in the United Kingdom, bite transmission
occurred and antibody prevalence was 67% in wild mice
that were caught (11). Over a few generations, every mem-
ber of a colony may become infected, as vertical transmis-
sion approaches 100% efficiency (12).
As was demonstrated by our results and suggested in
earlier research, serologic testing of rodents underestimated
overall infection rate (8), possibly because circulating anti-
bodies were lacking in vertically infected mice. Oldstone
and Dixon found that in the offspring of infected mice, anti-
bodies to LCMVwere sequestered in the kidneys and unde-
tectable in blood (13). In our study, results of serologic
testing on Nobuto strips were negative for all specimens,
while results of virus isolation and IFA from spleen
homogenates were positive for LCMV in 96% of M. mus-
culus that were sampled and in 85% of all animals  tested.
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confirmed by tissue testing, such as virus isolation and IFA,
or other methods, such as PCR. While most house mice
were infected, none of the fecal pellets collected from traps
were positive by virus isolation. This finding may be due to
the fragile nature of LCMV in the environment or the
predilection of the virus for rodent kidneys (14).
LCMV most likely represents an underdiagnosed,
endemic zoonotic disease. Future goals include public
health surveillance enhancements, physician education,
and epidemiologic studies. Surveillance can be improved
by adding LCMV to reportable disease lists and including
a question about rodent exposure on case report forms for
aseptic meningitis. Improved surveillance data can be used
to educate clinicians on the range of illnesses caused by
LCMV and the potential for acquired and congenital infec-
tion by exposure to rodents; this increased awareness
would increase diagnostic testing and case identification.
Improved case identification could lead to future studies to
determine potential environmental, social, and economic
risk factors, which would allow prevention and control
efforts to be focused on vulnerable populations.
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Figure. Methylamine tungstate negative-stain electron micrograph
of arenavirus isolated from mouse spleen homogenate cultures
that tested positive by immunofluorescence assay for lymphocytic
choriomeningitis virus infection. Viral envelope spikes and projec-
tions are visible, and virion inclusions show a sandy appearance,
indicating Arenaviridae.